Influenza A (H1N1) 2009 monovalent vaccine

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester

Conditions

2009 H1N1 InfluenzaH1N1 Influenza VirusHIV Infections

Phase 2

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

CompletedNCT00992836

National Institute of Allergy and Infectious Diseases (NIAID)H1N1 Influenza Virus, HIV Infections

Start: 2009-10-31End: 2010-08-31Updated: 2021-11-05

Phase 4

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children

WithdrawnNCT01097941

University of Rochester2009 H1N1 Influenza

Start: 2010-03-31End: 2010-09-30Updated: 2015-09-24

Related Papers

Characterization of Functional Antibody and Memory B-Cell Responses to pH1N1 Monovalent Vaccine in HIV-Infected Children and Youth

PLoS ONE2015-03-1813 citations

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.

2012-05-2119 citations